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Abstract
GlucosyIeeramide (GIeCer) is a major glycosphingolipid component of epidermis,
which is thought to be related to the barrier function of skin permeability. However, the
role of glycosphingolipids in keratinocyte growth and differentiation has not been fully
clarified. It has been reported that O-threo-l-phenyl-2-decanoylamino-3-morpholino-l-
propanol (POMP), an inhibitor of GIeCer synthase (EC 2.4.1.80), depletes cells of gly-
cosphingolipids. This inhibitor has been used as a tool for elucidating their functions. In
the present study, the effect of POMP on cultured normal human keratinocytes was inves-
tigated. The cells were treated with various concentrations of POMP. Forty-eight hours
later cell growth, thymidine incorporation, and lipid content were studied. The cell
growth and the incorporation of thymidine into cells were inhibited by POMP in a dose
dependent manner. The synthesis of GIeCer was strongly inhibited by POMP treatment,
whereas no significant changes in ceramide level were observed. We concluded that
GIeCer in epidermis may play an important role in regulating epidermal growth and sug-
gested that POMP may be beneficial for treating proliferative skin disorders in the future.
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Introduction
Recently, many studies using normal and
transformed cells have shown that glycosph-
ingolipids derived from GlcCer are involved
in a range of physiological activities includ-
ing cell proliferation, cell diferentiation,
and apoptosis (1-5). These lipids have been
proposed to act through regulation of cell
kinases, phosphatases, and gene transcrip-
tion (4, 5). On the basis of these studies, it is
suggested that glycosphingolipids in the epi-
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dermis might also play an important role in
regulating these cellular events.
I t has been reported that D-threo-l-
phenyl-2-decanoylamino-3-morpholino-l-
propanol (PDMP), an inhibitor of GlcCer
synthase (EC 2.4.1.80), depletes cells of gly-
cosphingolipids (6-8). Therefore, this in-
hibitor has been used as a tool for elucidat-
ing their functions. It has inhibited prolifer-
ation of cultured normal cells (9), has
shown chemotherapeutic action in cancer
(10, 11), and has reduced the ability of can-
cer cells to metastasize (12, 13). However,
the studies of the effects of this GlcCer syn-
thase inhibitor on keratinocytes have been
limited (14). In the present study, we investi-
gated the effect of PDMP on the prolifera-
tion and lipid contents of cultured human
keratinocytes.
Materials and Methods
Cell Culture
Normal human keratinocytes from healthy
DAYS IN CULTURE
Fig. 1. Effect of PDMP on Keratinocyte
Growth. The concentrations of PDMP in 11M
added to the culture medium are indicated in
the figure. Each value indicate the mean ± SD
in triplicate wells.
adult skin were cultured using a modification of
a previously described method (15). The cells
were grown in keratinocyte growth medium,
KGM (Keratinocyte SFM, Gibco, BRL, Grand Is-
land, NY, USA) at 37°C in 5% COj95% air.
KGM contained 2.5 ng/ml epidermal growth
factor, 35 Ilg/ml bovine pituitary extract, and
0.09 mM CaCI2• All experiments were carried
out using third or fourth passage keratinocytes
grown in KGM as described previously (16).
Effects ofPDMP on cellproliferation
The stock solution of 1.92 mM PDMP (Bio-
mol Research Laboratories, Inc. PA, USA)-140
mM fatty acid-free bovine serum albumin
(Sigma, St. Louis. Mo., USA) complex was pre-
pared as described elsewhere (7). Cells (4 x
104/well) were seeded into 24-well culture plates
(Corning Glass Works, NY, USA) coated with 25
Ilg/ml type IV collagen (Gibco BRL, USA) and
incubated at 37°C in 5% CO2/95% air. Eight
hours after seeding, by which time most of the
cells had attached to the floor of the well, PDMP
(0 to 40 11M in KGM) was added to the wells.
Two days and five days later, the wells were
washed with PBS, and the cells were dissociated
with 0.25% trypsin. Following testing with
trypan blue, the number of viable cells was
measured using a hemocytemeter.
Effect ofPDMP on DNA synthesis
Cells (1 x lOS/well) were seeded into 24-well
culture plates coated with type IV collagen and
incubated for 24 h at 37°C in 5% CO 2/95% air.
After this incubation, cells were exposed for
48 h to various concentrations of PDMP dis-
solved in KGM. The cells were incubated with 4
IlCi/ml [3H]thymidine (Amersham, Arlington,
Ill. USA) for the last 8 h of the PDMP treatment.
They were then washed 3 times with PBS. Then
0.5 ml of 1 N NaOH was added to each well, and
the sample was counted using a scintilation
counter (Beckman, USA).
Reversibility of the PDMP effect on ['H}thymidine
incorporation
In order to determine the toxicity of lower
concentrations of PDMP, the following study was
carried out. Cells were cultivated in a 75 mm"
culture dish (Corning Glass Works, NY, USA)
coated with type IV collagen as described above
and treated with or without 10 11M PDMP in
KGM for 48 h. The cells were then washed with
PBS 3 times and dissociated with 0.25% trypsin.
After centrifugation (500 rpm x 10 min), the
cells (1 x lOS/well) were placed in 24-well cul-
ture plates coated with type IV collagen and cul-
tured with KGM for another 48 h. For the final 8
hours of the culture, cells were labeled with
[3H]thymidine and counted as described above.
Lipid analysis
Cells grown in 6-well culture plates (Corning
Glass Works, NY, USA) coated with type IV colla-
gen were incubated for 48 hours with or without
PDMP. The cells then were washed 3 times with
cold PBS and trypsinized. The resultant cell sus-
pension was then centrifuged, and the pellet was
fixed with methanol (M). To extract lipids, an
equal volume of chloroform (C) was added to
each tube, and the tube was sonicated for 15
min in an ultrasonic bath. After centrifuging for
20 min at 2000xg, the pellet was again extracted
with a mixture of C:M=I:1 and centrifuged as
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Table I. Recovery of ["H] thymidine
incorporation of keratinocytes after
PDMP treatment
The cells were incubated for 48 hr in culture
medium with or without 5 JlM PDMP.
Each value indicates the mean ± SD of
glucosyIeeramide (GIeCer) or ceramide
(Cer) content (/lg/mg protein) in
triplicated determinations. *p<0.05 in
comparison with control.
Control 1.06±0.02 1.22±0.08
PDMP (5 /lM) 0.08±0.01* 1.30±0.03
Each value indicates mean ± SD in triplicate
wells. There were no significant differences
between the two groups.
Table 2. Effect of PDMP on
glycosphingolipids synthesis
test. However, at concentrations of more
than 20 IJ,M, cell death was observed in most
of the keratinocytes (Fig. 1).
Effect ofPDMP on [3H]thymidine incorpora-
tion
[3H] thymidine incorporation into cells
was inhibited by 48 hours of treatment with
PDMP in a dose-dependent manner. At the
concentration of 5 IJ,M, ['lH] thymidine in-
corporation was reduced to about 50% of
the control level (Fig. 2).
Reversibility of the PDMP effect on [3H]thymi-
dine incorporation
Cells that were incubated for 48 h in
PDMP-free medium after pretreatment with
10 IJ,M of PDMP showed complete recovery
(98% of controls) of the ability to incorpo-
rate thymidine into cells (Table 1).
Lipid analysis
GIeCer synthesis was strongly inhibited by
5 IJ,M PDMP (Table 2). The concentration
of GIeCer (Ilg/mg protein) was reduced to
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Fig. 2. Effect of PDMP on [~H] thymidine in-
corporation into DNA of keratinocytes. Each
value indicates the mean ± SD in triplicate
wells.
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described above. The resulting supernatants
were combined, and 0.9% NaCI was added until
the ratio of C:M:NaCI=2:1:0.8 to obtain phase
separation. This mixture was vortexed and then
centrifuged for 5 min at 800xg. The upper
phase was discarded, and lower phase was again
mixed with methanol and 0.9% NaCI; the ratio
of C:M:aqueous was 2:1:0.8. After centrifuga-
tion, the lower phase was transferred to another
tube and dried under a stream of nitrogen gas.
A part of the dried lipids dissolved in C:M (2:1)
was applied to an HPTLC plate (E. Merck silica
gel 60). Solvent systems consisting of C:M:W
(24:7:1) and C:acetic acid (9:1) were used for
GIeCer and Cer analysis, respectively.
Statistical analysis
Each study was triplicated. Non-paired t-analy-
sis was used for the statistical analysis.
Results
Effect ofPDMP on cellproliferation
Cell proliferation was inhibited by PDMP
in a dose-dependent manner. Below the
concentration of 20 IJ,M, the effect of PDMP
was not cytotoxic, and the cell viability was
assured by the trypan blue dye exclusion
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7 or 8% of the control value. The change in
Cer level was not significant after 48 h of
treatment with 5 u.M of PDMP.
Discussion
Glycosphingolipids, especially acyl-
GIeCer, have been shown to be major forms
of GIeCer in the basal and prickle layers of
epidermis and to hydrolyze to ceramide as
the cells become horny (17-20). The physi-
ological function of GIeCer in basal cells has
been unclear; however, recently Holleran et
al. indicated that GIeCer serves to stimulate
cell proliferation and that its conversion to
ceramide as the cells rise toward the skin
surface results in differentiation and loss of
proliferation (21, 22). Our results demon-
strated that PDMP significantly depleted the
GIeCer of cultured human keratinocytes,
which are thought to reflect the characteris-
tics of the basal keratinocytes, and inhibited
both their growth and [3H]thymidine incor-
poration. These findings are consistent with
the results of previous reports using other
cell lines and tissues. However, the mecha-
nism of.the effect ofPDMP and the relation-
ship between GIeCer depletion and growth
inhibition are not fully understood. Recent-
ly, it has been reported that sphingomyelin
breakdown products regulate cell growth,
differentiation, and apoptosis (1-5). In this
metabolic turnover of sphingomyelin,
sphingosine and ceramide are thought to
have major functional roles. From this point
of view, it may be an important question
whether GIeCer is the major candidate for
the inhibition of cellular growth by PDMP
treatment. Using a transformed human
keratinocyte cell line, Wakita et al. reported
that cell-permeant ceramides inhibited cell
growth and induced cell differentiation (3).
In our study, by 48 h treatment with PDMP,
at which time keratinocyte growth was
strongly inhibited, only the GIeCer level was
reduced; the change in Cer level was not sig-
nificant. This result suggests that GIeCer
regulates such cellular function by itself.
However, it is also possible that changes in
the ratio of GIeCer/ Cer related to sphin-
gomyclin metabolism may be a important
signal for regulation of keratinocyte func-
tion. Further study of the changes in sphin-
golipid composition by PDMP treatment is
needed to clarify the mechanism of PDMP
effects. Moreover, it is also important to in-
vestigate whether keratinocyte differentia-
tion and apoptosis are induced by PDMP
treatment.
PDMP has been expected to be'useful as a
new drug in cancer chemotherapy (10, 11).
However, it has not yet been used clinically
because its pharmacological safety and toxi-
city have not been established. If PDMP was
administered systemically, the depletion of
the cellular GIeCer level must occur in many
normal tissues and may result in damage to
them (10). However, it is possible that such
systemic side effects may be avoided or re-
duced if PDMP is applied topically. There
are many kinds of neoplastic or non-neo-
plastic proliferative skin disorders. Psoriasis
is the most common and benign of these;
squamous cell carcinoma is the most com-
mon skin cancer. Since PDMP inhibited epi-
dermal cell growth, this substance may have
therapeutic value in treating such proliferat-
ing skin disorders when applied topically.
Our result also suggests that the effect of
PDMP is reversible and not toxic at its lower
concentration. So it is possible that the toxi-
city to surrounding normal tissue by PDMP
topical application may be less than that re-
sulting from topical chemotherapy using
other anti-proliferative ointments such as 5-
fluorouracil ointment. Further pharmaco-
logical studies are needed to confirm the
benefit of PDMP for topical therapy of such
skin diseases in the future.
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